![Alice Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Alice Chen worked as the Executive Director-Clinical Operations at Skye Bioscience, Inc. from 2019 to 2020.
Prior to that, she was the Head-Clinical Operations at Zafgen, Inc. Ms. Chen received an undergraduate degree from the University of California San Diego.
Ehemalige bekannte Positionen von Alice Chen
Unternehmen | Position | Ende |
---|---|---|
SKYE BIOSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Alice Chen
University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SKYE BIOSCIENCE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |